Annual CFF
$9.97 M
-$3.86 M-27.89%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual cash flow from financing activities is $9.97 million, with the most recent change of -$3.86 million (-27.89%) on September 30, 2024.
- During the last 3 years, CTXR annual CFF has fallen by -$110.50 million (-91.72%).
- CTXR annual CFF is now -91.72% below its all-time high of $120.47 million, reached on September 30, 2021.
Performance
CTXR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$3.75 M
-$17.47 M-127.31%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly cash flow from financing activities is -$3.75 million, with the most recent change of -$17.47 million (-127.31%) on September 30, 2024.
- Over the past year, CTXR quarterly CFF has dropped by -$17.47 million (-127.31%).
- CTXR quarterly CFF is now -103.61% below its all-time high of $103.67 million, reached on March 31, 2021.
Performance
CTXR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$9.97 M
-$3.75 M-27.31%
September 30, 2024
Summary
- As of February 8, 2025, CTXR TTM cash flow from financing activities is $9.97 million, with the most recent change of -$3.75 million (-27.31%) on September 30, 2024.
- Over the past year, CTXR TTM CFF has dropped by -$3.75 million (-27.31%).
- CTXR TTM CFF is now -92.28% below its all-time high of $129.17 million, reached on June 30, 2021.
Performance
CTXR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CTXR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.9% | -127.3% | -27.3% |
| 3 y3 years | -91.7% | -127.3% | -27.3% |
| 5 y5 years | -10.5% | -127.3% | -27.3% |
CTXR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.7% | -100.0% | -127.2% | at low | -91.7% | -100.0% |
| 5 y | 5-year | -91.7% | -100.0% | -103.6% | at low | -92.3% | -100.0% |
| alltime | all time | -91.7% | -100.0% | -103.6% | at low | -92.3% | -100.0% |
Citius Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $9.97 M(-27.9%) | -$3.75 M(-127.3%) | $9.97 M(-27.3%) |
| Jun 2024 | - | $13.72 M(>+9900.0%) | $13.72 M(-0.6%) |
| Mar 2024 | - | $0.00(-100.0%) | $13.80 M(-0.2%) |
| Sep 2023 | $13.83 M(>+9900.0%) | -$700.00(-100.0%) | $13.83 M(-0.0%) |
| Jun 2023 | - | $13.80 M(>+9900.0%) | $13.83 M(>+9900.0%) |
| Mar 2023 | - | $31.30 K(>+9900.0%) | $31.30 K(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | $0.00(-100.0%) | - | - |
| Jun 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2022 | - | $0.00(0.0%) | $16.80 M(-86.1%) |
| Dec 2021 | - | $0.00(0.0%) | $120.47 M(-0.0%) |
| Sep 2021 | $120.47 M(+426.1%) | $0.00(-100.0%) | $120.47 M(-6.7%) |
| Jun 2021 | - | $16.80 M(-83.8%) | $129.17 M(+7.2%) |
| Mar 2021 | - | $103.67 M(>+9900.0%) | $120.54 M(+426.4%) |
| Dec 2020 | - | $500.00(-100.0%) | $22.90 M(+0.0%) |
| Sep 2020 | $22.90 M(+105.4%) | $8.70 M(+6.5%) | $22.90 M(+11.8%) |
| Jun 2020 | - | $8.17 M(+35.6%) | $20.49 M(+19.5%) |
| Mar 2020 | - | $6.03 M(>+9900.0%) | $17.15 M(+54.1%) |
| Dec 2019 | - | $100.00(-100.0%) | $11.13 M(-0.1%) |
| Sep 2019 | $11.15 M(-35.6%) | $6.29 M(+30.1%) | $11.15 M(-19.1%) |
| Jun 2019 | - | $4.83 M(>+9900.0%) | $13.78 M(+54.0%) |
| Mar 2019 | - | $7200.00(-55.0%) | $8.95 M(-16.4%) |
| Dec 2018 | - | $16.00 K(-99.8%) | $10.71 M(-38.1%) |
| Sep 2018 | $17.30 M(+58.9%) | $8.93 M(>+9900.0%) | $17.30 M(+16.8%) |
| Jun 2018 | - | $0.00(-100.0%) | $14.81 M(-14.6%) |
| Mar 2018 | - | $1.76 M(-73.3%) | $17.35 M(+5.6%) |
| Dec 2017 | - | $6.61 M(+2.7%) | $16.42 M(+50.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | $10.88 M(+106.8%) | $6.44 M(+153.4%) | $10.88 M(+123.0%) |
| Jun 2017 | - | $2.54 M(+202.8%) | $4.88 M(+76.2%) |
| Mar 2017 | - | $838.90 K(-21.4%) | $2.77 M(-54.0%) |
| Dec 2016 | - | $1.07 M(+145.2%) | $6.03 M(+14.5%) |
| Sep 2016 | $5.26 M(+248.7%) | $435.20 K(+1.4%) | $5.26 M(+0.1%) |
| Jun 2016 | - | $429.00 K(-89.5%) | $5.26 M(-6.9%) |
| Mar 2016 | - | $4.10 M(+1254.6%) | $5.65 M(+211.7%) |
| Dec 2015 | - | $302.40 K(-29.7%) | $1.81 M(+20.0%) |
| Sep 2015 | $1.51 M(+7263.4%) | $430.40 K(-47.5%) | $1.51 M(+39.9%) |
| Jun 2015 | - | $819.10 K(+215.0%) | $1.08 M(+248.1%) |
| Mar 2015 | - | $260.00 K(>+9900.0%) | $310.00 K(+520.0%) |
| Dec 2014 | - | $0.00(-100.0%) | $50.00 K(-92.1%) |
| Jun 2014 | - | $50.00 K(>+9900.0%) | $632.40 K(+8.0%) |
| Mar 2014 | - | $0.00(-100.0%) | $585.60 K(-1.6%) |
| Dec 2013 | - | $575.00 K(+7670.3%) | $595.30 K(+2803.9%) |
| Sep 2013 | $20.50 K(+1.5%) | $7400.00(+131.3%) | $20.50 K(+10.8%) |
| Jun 2013 | - | $3200.00(-67.0%) | $18.50 K(-13.6%) |
| Mar 2013 | - | $9700.00(+4750.0%) | $21.40 K(+17.6%) |
| Dec 2012 | - | $200.00(-96.3%) | $18.20 K(-9.9%) |
| Sep 2012 | $20.20 K(+9.2%) | $5400.00(-11.5%) | $20.20 K(+1.5%) |
| Jun 2012 | - | $6100.00(-6.2%) | $19.90 K(+4.7%) |
| Mar 2012 | - | $6500.00(+195.5%) | $19.00 K(-1.0%) |
| Dec 2011 | - | $2200.00(-56.9%) | $19.20 K(+3.8%) |
| Sep 2011 | $18.50 K | $5100.00(-1.9%) | $18.50 K(+38.1%) |
| Jun 2011 | - | $5200.00(-22.4%) | $13.40 K(+63.4%) |
| Mar 2011 | - | $6700.00(+346.7%) | $8200.00(+446.7%) |
| Dec 2010 | - | $1500.00 | $1500.00 |
FAQ
- What is Citius Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual CFF year-on-year change?
- What is Citius Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly CFF year-on-year change?
- What is Citius Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM CFF year-on-year change?
What is Citius Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CTXR is $9.97 M
What is the all time high annual CFF for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual cash flow from financing activities is $120.47 M
What is Citius Pharmaceuticals annual CFF year-on-year change?
Over the past year, CTXR annual cash flow from financing activities has changed by -$3.86 M (-27.89%)
What is Citius Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CTXR is -$3.75 M
What is the all time high quarterly CFF for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly cash flow from financing activities is $103.67 M
What is Citius Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CTXR quarterly cash flow from financing activities has changed by -$17.47 M (-127.31%)
What is Citius Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CTXR is $9.97 M
What is the all time high TTM CFF for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM cash flow from financing activities is $129.17 M
What is Citius Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CTXR TTM cash flow from financing activities has changed by -$3.75 M (-27.31%)